North America PET-CT Scanning Services Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

North America PET-CT Scanning Services Market Size

• The North America PET-CT Scanning Services Market size was valued at USD 7.76 billion in 2025 and is expected to reach USD 11.46 billion by 2033, at a CAGR of 5.2% during the forecast period
• PET-CT scanning services refer to diagnostic imaging solutions that combine Positron Emission Tomography (PET) and Computed Tomography (CT) technologies into a single integrated system. This hybrid imaging technique captures metabolic activity through PET and anatomical details through CT, allowing clinicians to detect, stage, and monitor diseases with high precision. The service includes scan procedures, radiotracer administration, image interpretation, and reporting performed in hospitals, diagnostic centers, and specialized imaging facilities.
• The North America PET-CT Scanning Services Market is experiencing steady growth as healthcare systems increasingly prioritize early and accurate disease diagnosis, particularly for cancer, cardiovascular disorders, and neurological conditions. The demand is driven primarily by rising North America cancer incidence, expanding applications of hybrid imaging in precision medicine, and growing clinician preference for combined metabolic and anatomical imaging to improve diagnostic accuracy.

North America PET-CT Scanning Services Market Analysis

• Technological advancements such as digital PET, AI-enabled image reconstruction, and low-dose CT are enhancing scan quality and operational efficiency, further strengthening market adoption. Additionally, the shift toward outpatient imaging centers, expanding reimbursement support in developed markets, and growing investment in diagnostic infrastructure across emerging economies are boosting service availability.
• The high equipment costs, shortages of skilled radiologists and nuclear medicine specialists, and limited access to radiopharmaceuticals in low-income regions continue to challenge widespread utilization. Overall, the market is evolving toward more accessible, high-precision, and workflow-optimized PET-CT services in North America.
• The U.S. is expected to dominate with 83.07% market share and is expected to grow with the highest CAGR of 5.3% in the forecast period of 2026 to 2033 due to its well-established diagnostic imaging infrastructure, high adoption of advanced PET-CT technologies, and strong clinical demand driven by the rising prevalence of cancer and chronic diseases.
• In 2026, the standalone PET-CT scanning services segment is expected to dominate with 63.51% market share due to its higher patient throughput capacity, wider accessibility, and strong preference among healthcare providers for dedicated imaging facilities that offer faster appointments and specialized diagnostic expertise. Standalone centers typically operate with extended hours, advanced equipment, and efficient workflow models, enabling them to deliver quicker turnaround times and cost-effective services compared to hospital-based units

Report Scope and North America PET-CT Scanning Services Market Segmentation 

North America PET-CT Scanning Services Market Trends

“Rapid integration of AI-driven imaging analytics and workflow automation”

• Providers are increasingly adopting AI-enabled PET-CT platforms that assist radiologists in detecting early-stage cancers, cardiovascular abnormalities, and neurodegenerative conditions with greater precision by automatically analyzing metabolic and anatomical data, identifying subtle lesion characteristics, and reducing interpretation variability.
• This trend is driven by the rising burden of oncology cases, the North America shift toward value-based care, and the need for faster, more reliable imaging outcomes.
• AI-powered reconstruction algorithms are significantly lowering radiation dose while improving image quality, making PET-CT services safer and more accessible for a wider patient population.
• Additionally, automated scheduling, reporting, and image-sharing tools are helping imaging centers manage high patient volumes, reduce turnaround times, and improve inter-departmental communication.
• The combination of AI, cloud-based imaging platforms, and hybrid diagnostic workflows is positioning PET-CT scanning services as a critical pillar of advanced precision medicine, supporting personalized treatment planning, real-time treatment monitoring, and improved patient outcomes worldwide.

North America PET-CT Scanning Services Market Dynamics

Driver

“Increasing incidence of cancer and neurological disorders”

• Increasing incidence of cancer and neurological disorders has become a foundational force propelling growth in the North America PET-CT Scanning Services Market. As the prevalence of cancers and neurodegenerative or neurological conditions rises worldwide, demand for high-precision diagnostic imaging such as PET-CT has intensified.
• PET-CT offers critical advantages in early detection, accurate staging, treatment planning and monitoring for oncology and certain neurological indications — making it a preferred diagnostic modality where disease burden increases. Consequently, the escalation in cancer and neurological disorders North America has translated into higher utilization rates of PET-CT services and is driving geographic expansion of diagnostic infrastructure.

• For instance- in February 2024, the World Health Organization reported that there were approximately 20 million new cancer cases worldwide in 2022, and projected North America cancer incidence to reach around 35 million by 2050, indicating a substantial increase in oncology patient volume North America

• The North America escalation in cancer and neurological disease prevalence is being firmly established as a permanent structural growth engine for PET-CT scanning services. The continuous rise in new cancer diagnoses, coupled with the expanding population living with chronic neurological disorders, is creating a sustained and non-cyclical need for high-precision molecular imaging.
• As treatment protocols become increasingly personalized and therapy monitoring becomes mandatory across oncology and neurology, reliance on PET-CT for disease staging, prognosis evaluation, and therapeutic monitoring is being intensively strengthened.

Restraint/Challenge

“Operational challenges in public sector hospitals”

• Public sector hospitals across many regions face persistent operational challenges that directly affect service delivery, patient management, and overall healthcare efficiency. Limited budget allocations often lead to shortages of essential equipment, delayed maintenance, and constraints in diagnostic infrastructure, including imaging services.
• Workforce shortages—particularly in specialized areas such as radiology, nuclear medicine, and advanced imaging operations—further strain capacity, resulting in long patient wait times and reduced throughput. Bureaucratic procurement processes slow down the adoption of advanced technologies and restrict the timely availability of consumables and radiopharmaceuticals
• For Instance- In February 2025, a Comptroller and Auditor General of India (CAG) report on Delhi’s public-health infrastructure revealed that about 21% of staff positions in the health department were vacant, with specialist shortages (super-specialists) as high as 30%. The audit also flagged a lack of essential equipment and consumables, under-utilized radiological diagnostic services, and very long waiting times for major surgeries — showing serious operational bottlenecks in tertiary hospitals.
• The operational constraints highlighted across public-sector hospitals—such as non-functional diagnostic equipment, prolonged waiting times, specialist shortages, and incomplete infrastructure development—underscore a widening structural gap between diagnostic demand and public-sector capacity.
• From a market perspective, this creates a significant avenue for growth in advanced imaging services, as public systems increasingly rely on external diagnostic networks, PPP models, and private facilities to meet rising clinical volumes.

North America PET-CT Scanning Services Market Scope

North America PET-CT Scanning Services Market is categorized into six notable segments which are based on service type, scan type, tracer type, application, end users, and distribution channel.

• By Service Type

On the basis of service type, North America PET-CT Scanning Services Market is segmented into standalone PET-CT scanning services, onsite PET-CT scanning services, and Mobile PET-CT scanning services. In 2026, the standalone PET-CT scanning services segment is expected to dominate with 63.51% market share due to its established infrastructure, higher scan volumes, cost efficiency per scan, and strong preference among healthcare providers for fixed imaging centers offering advanced diagnostic capabilities.

The mobile PET-CT scanning services segment is growing with the highest CAGR of 6.1% due to increasing demand in remote and underserved areas, rising adoption by smaller hospitals and clinics, improved logistical flexibility, and reduced capital investment compared to fixed installations.

• By Scan Type

On the basis of scan type, the North America PET-CT Scanning Services Market is segmented into whole body scans, partial body scans. In 2026, the whole body scans segment is expected to dominate with 85.81% market share due to its wide clinical applicability, ability to provide comprehensive disease assessment in a single procedure, and strong adoption for cancer staging and treatment monitoring.

The whole-body scans segment is growing with the highest CAGR of 5.2% due to its critical role in comprehensive disease detection, staging, and therapy response evaluation across oncology, cardiology, and neurology applications.

• By Tracer Type

On the basis of tracer type, the North America PET-CT Scanning Services Market is segmented into FDG (fluorodeoxyglucose), non-FDG tracers, new/emerging tracers. In 2026, the FDG (fluorodeoxyglucose) segment is expected to dominate with 77.48% market share due to its long-standing clinical acceptance, broad diagnostic utility across multiple disease areas, and widespread availability in PET-CT imaging centers globally.

The new/emerging tracers segment is growing with the highest CAGR of 6.1% due to increasing research advancements, rising adoption for targeted and personalized diagnostics, and expanding applications in neurology and precision oncology.

• By Application

On the basis of application, the North America PET-CT Scanning Services Market is segmented into oncology, neurology, cardiology, infectious diseases, inflammatory diseases, others (orthopedic, pediatrics). In 2026, oncology segment is expected to dominate with 63.97% market share due to the high prevalence of cancer, widespread use of PET-CT for tumor detection and staging, and its critical role in treatment planning and monitoring.

The neurology segment is growing with the highest CAGR of 5.8% due to increasing incidence of neurological disorders, growing use of PET-CT in early disease diagnosis, and rising demand for advanced brain imaging techniques.

• By End User

On the basis of end user, the North America PET-CT Scanning Services Market is segmented into hospitals, diagnostic, imaging centers, specialty clinics, research institutes, others. In 2026, hospitals segment is expected to dominate with 54.64% market share due to the availability of integrated healthcare infrastructure, higher patient inflow, and the ability to offer PET-CT services as part of comprehensive diagnostic and treatment pathways.

The diagnostic imaging centers segment is growing with the highest CAGR of 5.7% due to increasing referral volumes, expanding standalone imaging facilities, and growing patient preference for specialized centers offering faster turnaround times.

• By Distribution Channel

On the basis of distribution channel, the North America PET-CT Scanning Services Market is segmented into direct, indirect. In 2026, the direct segment is expected to dominate the with 76.11% market share due to better operational control, direct patient engagement, and improved coordination between imaging service providers and healthcare institutions.

The indirect segment is growing with the highest CAGR of 6.1% due to expanding partnerships with third-party service providers, wider regional reach, and increasing reliance on referral networks to improve service accessibility.

North America PET-CT Scanning Services Market Regional Analysis

• U.S. dominates the North America PET-CT Scanning Services Market, accounting for 83.07% of the total share in 2026, and the region’s leadership is driven by its highly advanced healthcare infrastructure, early adoption of innovative imaging technologies, strong presence of leading diagnostic service providers, and substantial investments in oncology and cardiology imaging. The region benefits from widespread availability of hybrid PET-CT scanners, high reimbursement coverage for cancer diagnostics, and continuous technological advancements such as AI-assisted imaging, low-dose PET techniques, and radiotracer innovation. Additionally, a growing burden of chronic diseases, increased awareness of early diagnosis, and strong government and private sector support for molecular imaging research further reinforce North America’s dominant market position during the forecast period.
• U.S, registering the highest CAGR of 5.3% among all countries, and this growth is driven by rapid healthcare infrastructure expansion, rising investments in advanced diagnostic imaging, and increasing adoption of PET-CT technology for early cancer detection across emerging economies such. The region benefits from a growing prevalence of oncology and neurological disorders, improving access to nuclear medicine facilities, and government initiatives aimed at strengthening radiology and diagnostic capabilities. Additionally, increasing private-sector participation, rising medical tourism, expansion of specialized imaging centers, and greater affordability of PET-CT procedures contribute significantly to U.S. market acceleration during the forecast period

North America PET-CT Scanning Services Market Insight

The North America PET-CT Scanning Services Market is experiencing steady and strong growth, driven by its highly advanced healthcare infrastructure, early adoption of innovative imaging technologies, strong presence of leading diagnostic service providers, and substantial investments in oncology and cardiology imaging. The region benefits from widespread availability of hybrid PET-CT scanners, high reimbursement coverage for cancer diagnostics, and continuous technological advancements such as AI-assisted imaging, low-dose PET techniques, and radiotracer innovation. Additionally, a growing burden of chronic diseases, increased awareness of early diagnosis, and strong government and private sector support for molecular imaging research further reinforce North America’s dominant market position during the forecast period.

U.S. North America PET-CT Scanning Services Market Insight

The U.S. is the dominant country in the North American North America PET-CT Scanning Services Market, accounting for 83.07% of the region’s share in 2026, and is projected to grow at a strong CAGR of 5.3% from 2026 to 2033, driven by its highly sophisticated healthcare ecosystem, widespread availability of PET-CT scanners, and strong uptake of advanced molecular imaging in oncology, cardiology, and neurology. The country benefits from robust reimbursement frameworks, rapid integration of AI-based diagnostic tools, and significant investments in precision medicine and radiopharmaceutical development.

Canada North America PET-CT Scanning Services Market Insights

Canada holds 10.72% of the North American North America PET-CT Scanning Services Market in 2026 and is expected to grow at a CAGR of 4.7% from 2026 to 2033, driven by increasing investments in advanced diagnostic imaging infrastructure, rising adoption of PET-CT technology for oncology, neurology, and cardiology applications, and a growing emphasis on early disease detection within the public healthcare system. The country is witnessing steady expansion of nuclear medicine facilities, improved access to radiotracers, and greater collaboration between hospitals, imaging centers, and research institutions. Additionally, supportive government initiatives, favorable reimbursement policies, and ongoing modernization of medical imaging equipment across provinces further contribute to Canada’s sustained market growth during the forecast period.

North America PET-CT Scanning Services Market Share

The North America PET-CT Scanning Services Market is primarily led by well-established companies, including:

• C-HCA, Inc. (U.S.)
• Siemens Healthineers AG (Germany)
• RadNet, Inc. (U.S.)
• GenesisCare (Australia)
• I-MED Radiology Network (Australia)
• Medica Group Ltd (U.K.)
• Capitol Imaging Services (U.S.)
• Shared Medical Services Inc. (U.S.)
• Circle Health Group Ltd (U.K.)
• Fortis Healthcare (India)
• Alliance Medical Limited (U.K.)
• InHealth Group (U.K.)
• Dignity Health (U.S.)
• Apollo Hospitals Enterprises Ltd. (India)
• NM Medical (India)
• Nueclear (India)
• Cobalt Health (U.K.)
• DMS Health (U.S.)
• Cardiac Imaging, Inc. (U.S.)
• Alliance-HNI Health Care Services (U.S.)

Latest Developments in North America PET-CT Scanning Services Market

• In October 2025, RadNet’s DeepHealth division signed a letter of intent with GE Healthcare to jointly accelerate innovation and adoption of AI-powered imaging across multiple modalities. The agreement aims to expand access to advanced imaging technologies, support remote scanning workflows, and integrate AI tools to enhance diagnostic accuracy and reporting efficiency.
• In November 2025, RadNet acquired UK-based imaging services firm Cimar UK — a move that strengthens DeepHealth’s capabilities in AI-powered imaging reporting and image-based screening. The acquisition is expected to boost RadNet’s footprint in Europe and accelerate its ambition to deliver remote diagnostics and AI-enhanced imaging services North America.
• In November 2025, RadNet expanded its remote scanning services through the acquisition of assets from Alpha‑RT. This expansion enhances RadNet’s end-to-end remote imaging offering, enabling broader service availability and improved capacity for distributed diagnostic workflows.
• In October 2025, I‑MED opened its first PET/CT scanning facility at Mater Private Hospital Rockhampton — bringing advanced PET/CT diagnostic imaging locally to Central Queensland. This development ends the need for patients to travel over 300 km to undergo PET/CT scans in other cities, improving access to timely diagnostics for cancer, cardiac and neurological conditions. I‑MED’s installation represents a broader push toward equitable regional healthcare by extending high-quality imaging services beyond metropolitan centres.
• In August 2020, I‑MED Radiology Network announced that it would acquire Alfred Medical Imaging — a well‑established imaging provider offering a full range of diagnostic services including MRI and PET/CT. This move significantly expanded I‑MED’s presence in New South Wales, adding six clinics in Sydney’s Inner West, one at Mater Hospital in North Sydney, along with existing contracts to provide radiologist reporting services to public health authorities.

SKU-75161